Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma
Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma have?
Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma has 790 citations in the OpenAlex counts ScholarIQ stores.
When was Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma published?
Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma has 2014 year in the ScholarIQ index.
What is the open-access status of Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma?
Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma has bronze oa status in the ScholarIQ index.
What is the DOI of Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma?
The DOI for Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma is on the source record.
What is the PMID of Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma?
The PMID for Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma is on the source record.
What is the OpenAlex record for Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma?
The OpenAlex for Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma is on the source record.